Tavapadon met the primary endpoint in the pivotal Phase 3 TEMPO-2 flexible-dose monotherapy trial, demonstrating a statistically significant improvement from baseline in the MDS-UPDRS Parts II and III combined score… Read More
The Legal 500 Canada has recognized Mintz in its 2025 guide of the best Canadian firms and lawyers practicing within the Canadian market, based on extensive research conducted by the directory over… Read More
New insights show Black, Hispanic, and Asian patients have more negative emotional experiences and outlooks with their chronic lymphocytic leukemia (CLL) diagnosis and treatment journeys CLL is one of the… Read More
Data presented at the 66th Annual Meeting and Exposition of the American Society of Hematology (ASH) NORTH CHICAGO, ILL – AbbVie (NYSE: ABBV) announced updated results from the Phase 1b/2 EPCORE® NHL-2… Read More
The 2024 Canadian Cannabis Survey provides important insights into Canadians’ knowledge, attitudes and behaviours on cannabis use OTTAWA, ON – An important part of the Government of Canada’s public health… Read More
